Casadei, Beatrice; Broccoli, Alessandro; Stefoni, Vittorio; Pellegrini, Cinzia; Marangon, Miriam; Morigi, Alice; Nanni, Laura; Lolli, Ginevra; Carella, Matteo; Argnani, Lisa; Cavo, Michele; Zinzani, Pier Luigi, PD-1 blockade as bridge to allogenic stem cell transplantation in relapsed/refractory Hodgkin lymphoma patients: a retrospective single center case series, «HAEMATOLOGICA», 2019, 104, pp. e521 - e522 [Scientific article]Open Access
Usmani, Sz; Schjesvold, F; Oriol, A; Karlin, L; Cavo, M; Rifkin, Rm; Yimer, Ha; Leblanc, R; Takezako, N; Mccroskey, Rd; Lim, Abm; Suzuki, K; Kosugi, H; Grigoriadis, G; Avivi, I; Facon, T; Jagannath, S; Lonial, S; Ghori, Ru; Farooqui, Mzh; Marinello, P; San-Miguel, J; KEYNOTE-185 Investigators., Lim A; Grigoriadis, G; Walker, T; Nicol, A; Leblanc, R; Reece, D; Elemary, M; Boudreault Pedneault, Js; Karlin, L; Facon, T; Attal, M; Weisel, K; Engelhardt, M; Mackensen, A; Quinn, J; Avivi, I; Cohen, A; Magen-Nativ, H; Benyamini, N; Larocca, A; Takezako, N; Suzuki, K; Kosugi, H; Matsumoto, M; Iida, S; Ishikawa, T; Kondo, Y; Sunami, K; Ando, K; Teshima, T; Chou, T; Iwasaki, H; Miki, H; Matsumura, I; Onishi, Y; Izutsu, K; Kizaki, M; George, A; Blacklock, H; Simpson, D; Schjesvold, F; Waage, A; Samoilova, O; Nikitin, E; Chagorova, T; Mcdonald, A; Patel, M; Oriol Rocafiguera, A; San Miguel Izquierdo, J; Mateos, M; Streetly, M; Forsyth, P; Jackson, G; Jenkins, S; Rifkin, R; Yimer, H; Mccroskey, R;, Pembrolizumab plus lenalidomide and dexamethasone for patients with treatment-naive multiple myeloma (KEYNOTE-185): a randomised, open-label, phase 3 trial, «THE LANCET. HAEMATOLOGY», 2019, 6, pp. 448 - 458 [Scientific article]
Mateos, Maria-Victoria; Blacklock, Hilary; Schjesvold, Fredrik; Oriol, Albert; Simpson, David; George, Anupkumar; Goldschmidt, Hartmut; Larocca, Alessandra; Chanan-Khan, Asher; Sherbenou, Daniel; Avivi, Irit; Benyamini, Noam; Iida, Shinsuke; Matsumoto, Morio; Suzuki, Kenshi; Ribrag, Vincent; Usmani, Saad Z; Jagannath, Sundar; Ocio, Enrique M; Rodriguez-Otero, Paula; San Miguel, Jesus; Kher, Uma; Farooqui, Mohammed; Liao, Jason; Marinello, Patricia; Lonial, Sagar; KEYNOTE-183 Investigators; Nicol A, Grigoriadis G, Catalano J, LeBlanc R, Elemary M, Bahlis N, Facon T, Karlin L, Ribrag V, Attal M, Goldschmidt H, Engelhardt M, Weisel K, Mackensen A, Nagler A, Ben Yehuda D, Avivi I, Benyamini N, Magen-Nativ H, Palumbo A, Cavo M, Tobinai K, Iida S, Chou T, Suzuki K, Kosugi H, Taniwaki M, Sunami K, Matsumoto M, Ando K, Ganly P, Blacklock H, Simpson D, George A, Schjesvold F, Gjertsen B, Lahuerta J, Blade J, Oriol Rocafiguera A, Mateos M, Rodriguez-Otero P, Larson S, Atanackovic D, Devarakonda, Pembrolizumab plus pomalidomide and dexamethasone for patients with relapsed or refractory multiple myeloma (KEYNOTE-183): a randomised, open-label, phase 3 trial, «THE LANCET. HAEMATOLOGY», 2019, 6, pp. 459 - 469 [Scientific article]
Mateos, Maria-Victoria; Blacklock, Hilary; Schjesvold, Fredrik; Oriol, Albert; Simpson, David; George, Anupkumar; Goldschmidt, Hartmut; Larocca, Alessandra; Chanan-Khan, Asher; Sherbenou, Daniel; Avivi, Irit; Benyamini, Noam; Iida, Shinsuke; Matsumoto, Morio; Suzuki, Kenshi; Ribrag, Vincent; Usmani, Saad Z; Jagannath, Sundar; Ocio, Enrique M; Rodriguez-Otero, Paula; San Miguel, Jesus; Kher, Uma; Farooqui, Mohammed; Liao, Jason; Marinello, Patricia; Lonial, Sagar; KEYNOTE-183 Investigators; Nicol A, Grigoriadis G, Catalano J, LeBlanc R, Elemary M, Bahlis N, Facon T, Karlin L, Ribrag V, Attal M, Goldschmidt H, Engelhardt M, Weisel K, Mackensen A, Nagler A, Ben Yehuda D, Avivi I, Benyamini N, Magen-Nativ H, Palumbo A, Cavo M, Tobinai K, Iida S, Chou T, Suzuki K, Kosugi H, Taniwaki M, Sunami K, Matsumoto M, Ando K, Ganly P, Blacklock H, Simpson D, George A, Schjesvold F, Gjertsen B, Lahuerta J, Blade J, Oriol Rocafiguera A, Mateos M, Rodriguez-Otero P, Larson S, Atanackovic D, Devarakonda, Pembrolizumab plus pomalidomide and dexamethasone for patients with relapsed or refractory multiple myeloma (KEYNOTE-183): a randomised, open-label, phase 3 trial, «THE LANCET. HAEMATOLOGY», 2019, 6, pp. 459 - 469 [Scientific article]
Richardson, Paul G; Oriol, Albert; Beksac, Meral; Liberati, Anna Marina; Galli, Monica; Schjesvold, Fredrik; Lindsay, Jindriska; Weisel, Katja; White, Darrell; Facon, Thierry; San Miguel, Jesus; Sunami, Kazutaka; O'Gorman, Peter; Sonneveld, Pieter; Robak, Pawel; Semochkin, Sergey; Schey, Steve; Yu, Xin; Doerr, Thomas; Bensmaine, Amine; Biyukov, Tsvetan; Peluso, Teresa; Zaki, Mohamed; Anderson, Kenneth; Dimopoulos, Meletios; OPTIMISMM trial investigators; Abildgaard N, Adler H, Altuntas F, Akay OM, Amin B, Anagnostopoulos A, Anderson L, Anttila P, Araujo C, Arce-Lara C, Aydin Y, Basu S, Battini R, Beeker T, Benboubker L, Ben-Yehuda D, Bladé J, Blau IW, Boccia R, Burke L, Byeff P, Cascavilla N, Cavo M, Chantry A, Charles Y, Chaudhry A, Corso A, Coyne M, De Arriba F, Delimpasi S, Desjardins P, Dhakal B, Di Bartolomeo P, Di Raimondo F, Dürig J, Engelhardt M, Escoffre-Barbe M, Esteves G, Flogegard M, Gabrail N, Gamberi B, Garrison M, Gay J, Gisslinger H, Goldschmidt H, Goncalves C, Gress, Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial, «THE LANCET. HAEMATOLOGY», 2019, 20, pp. 781 - 794 [Scientific article]
Bringhen, S; Milan, A; D'Agostino, M; Ferri, C; Wäsch, R; Gay, F; Larocca, A; Offidani, M; Zweegman, S; Terpos, E; Goldschmidt, H; Cavo, M; Ludwig, H; Driessen, C; Auner, H W; Caers, J; Gramatzki, M; Dimopoulos, M A; Boccadoro, M; Einsele, H; Sonneveld, P; Engelhardt, M, Prevention, monitoring and treatment of cardiovascular adverse events in myeloma patients receiving carfilzomib A consensus paper by the European Myeloma Network and the Italian Society of Arterial Hypertension, «JOURNAL OF INTERNAL MEDICINE», 2019, 286, pp. 63 - 74 [Scientific article]
Solli, Vincenza; Poletti, Andrea; Martello, Marina; Pantani, Lucia; Borsi, Enrica; Termini, Rosalinda; Zamagni, Elena; Tacchetti, Paola; Mancuso, Katia; Cifarelli, Luca Nunzio; Mawulolo Agboyi, Lakpo Yaovi; marzocchi, giulia; Testoni, Nicoletta; Cavo, Michele; Terragna, Carolina, Rare, but complex chromosomal rearrangements, defined "Chromoanagenesis”, caused by single-step or stepwise catastrophic genomic events, significantly impact on Multiple Myeloma patients, «CLINICAL LYMPHOMA MYELOMA & LEUKEMIA», 2019, 19, pp. e78 - e79 [Abstract]
Follo, M. Y.; Pellagatti, A.; Armstrong, R. N.; Ratti, S.; Mongiorgi, S.; De Fanti, S.; Bochicchio, M. T.; Russo, D.; Gobbi, M.; Miglino, M.; Parisi, S.; Martinelli, G.; Cavo, M.; Luiselli, D.; Mccubrey, J. A.; Suh, P. -G.; Manzoli, L.; Boultwood, J.; Finelli, C.; Cocco, L., Response of high-risk MDS to azacitidine and lenalidomide is impacted by baseline and acquired mutations in a cluster of three inositide-specific genes, «LEUKEMIA», 2019, 33, pp. 2276 - 2290 [Scientific article]Open Access
Stanzani, Marta; Cricca, Monica; Sassi, Claudia; Sutto, Emanuele; DE CICCO, Gabriella; Bonifazi, Francesca; Bertuzzi, Clara; Bacci, Francesco; Paolini, Stefania; Cavo, Michele; Lewis, Russell E., Saprochaete clavata infections in patients undergoing treatment for haematological malignancies: A report of a monocentric outbreak and review of the literature, «MYCOSES», 2019, 62, pp. 1100 - 1107 [Scientific article]
Morigi, Alice; Casadei, Beatrice; Argnani, Lisa; Cavo, Michele; Zinzani, Pier Luigi, Spontaneous remission of follicular lymphoma, «HEMATOLOGY ONCOLOGY NEWS & ISSUES», 2019, 37, pp. 626 - 627 [Scientific article]
Nanni, Laura; Pellegrini, Cinzia; Stefoni, Vittorio; Argnani, Lisa; Cavo, Michele; Zinzani, Pier Luigi, Successful Employment of Brentuximab Vedotin in a Patient Undergoing Hemodialysis: The First Real-life Experience, «CLINICAL LYMPHOMA MYELOMA & LEUKEMIA», 2019, 19, pp. 595 - 596 [Scientific article]
Ciciarello, Marilena; Corradi, Giulia; Loscocco, Federica; Visani, Giuseppe; Monaco, Federica; Cavo, Michele; Curti, Antonio; Isidori, Alessandro, The Yin and Yang of the Bone Marrow Microenvironment: Pros and Cons of Mesenchymal Stromal Cells in Acute Myeloid Leukemia, «FRONTIERS IN ONCOLOGY», 2019, 9, pp. 1135 - 1135 [Scientific article]Open Access
Palandri, Francesca; Catani, Lucia; Auteri, Giuseppe; Bartoletti, Daniela; Fatica, Sofia; Fusco, Alessio; Bacchi Reggiani, Maria L; Cavo, Michele; Vianelli, Nicola, Understanding how older age drives decision-making and outcome in Immune Thrombocytopenia. A single centre study on 465 adult patients, «BRITISH JOURNAL OF HAEMATOLOGY», 2019, 184, pp. 424 - 430 [Scientific article]
Mohty, Mohamad; Cavo, Michele; Fink, Leah; Gonzalez-McQuire, Sebastian; Leleu, Henri; Mateos, Maria-Victoria; Raab, Marc S; Schoen, Paul; Yong, Kwee, Understanding mortality in multiple myeloma: Findings of a European retrospective chart review, «EUROPEAN JOURNAL OF HAEMATOLOGY», 2019, 103, pp. 107 - 115 [Scientific article]
Poletti, Andrea; Martello, Marina; Solli, Vincenza; Borsi, Enrica; Termini, Rosalinda; Cifarelli, Luca Nunzio; Mawulolo Agboyi, Lakpo Yaovi; Pantani, Lucia; Zamagni, Elena; Tacchetti, Paola; Mancuso, Katia; Cavo, Michele; Terragna, Carolina, VarianThinker: a classification method to confidently approach the mutation heterogeneity in Multiple Myeloma, in: 17th International Myeloma Workshop, 3500 MAPLE AVENUE, STE 750, DALLAS, TX 75219-3931 USA, CIG MEDIA GROUP, LP, «CLINICAL LYMPHOMA MYELOMA & LEUKEMIA», 2019, 19, pp. e72 - e73 (atti di: International Myeloma Workshop, Boston, 12/09/2019 - 15/09/2019) [Contribution to conference proceedings]
